Cargando…
Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice
Liraglutide, a glucagon-like peptide-1 analog, has beneficial metabolic effects in patients with type 2 diabetes and obesity. Although the high efficacy of liraglutide as an anti-diabetic and anti-obesity drug is well known, liraglutide-induced metabolic alterations in diverse tissues remain largely...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730228/ https://www.ncbi.nlm.nih.gov/pubmed/36356900 http://dx.doi.org/10.1016/j.jbc.2022.102682 |